REGENEREX PHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Regenerex Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Regenerex Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 278M shares, a 0.19% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 278M +520K +0.19% Nov 4, 2024 10-Q 2024-11-04
Q2 2024 278M +1.08M +0.39% Jun 24, 2024 10-K 2024-06-24
Q4 2023 278M +883K +0.32% Feb 5, 2024 10-Q 2024-02-05
Q3 2023 278M +803K +0.29% Nov 8, 2023 10-Q 2023-11-08
Q2 2023 277M +35K +0.01% Jun 9, 2023 10-K 2023-06-09
Q4 2022 277M 0 0% Jan 24, 2023 10-Q 2023-01-24
Q3 2022 277M +150M +118% Nov 7, 2022 10-Q 2022-11-07
Q2 2022 277M +150M +118% Jun 28, 2022 10-K 2022-06-28
Q4 2021 277M +150M +118% Feb 2, 2022 10-Q/A 2022-02-03
Q3 2021 127M 0 0% Nov 1, 2021 10-Q 2021-11-01
Q2 2021 127M 0 0% Jun 23, 2021 10-K 2021-06-23
Q4 2020 127M 0 0% Feb 12, 2021 10-Q 2021-02-11
Q3 2020 127M Nov 10, 2020 10-Q 2020-11-10
Q2 2020 127M 0 0% Jun 23, 2020 10-K/A 2020-08-11
Q4 2019 127M 0 0% Feb 11, 2020 10-Q 2020-02-10
Q2 2019 127M 0 0% Jul 15, 2019 10-Q 2019-10-30
Q1 2019 127M May 15, 2019 10-K 2019-06-24
Q4 2018 127M +10.3M +8.77% Jan 30, 2019 10-Q 2019-02-04
Q3 2018 127M -29M -18.6% Nov 12, 2018 10-Q 2018-11-13
Q2 2018 127M -29M -18.6% Jun 21, 2018 10-K 2018-06-21
Q4 2017 117M Feb 8, 2018 10-Q 2018-02-08
Q3 2017 156M Oct 18, 2017 10-Q 2017-11-07
Q2 2017 156M Jul 28, 2017 10-Q 2017-08-07
Q4 2014 156M +5.28M +3.49% Jan 30, 2015 10-K 2015-03-03
Q3 2014 156M +5.29M +3.5% Oct 10, 2014 10-Q 2014-10-20
Q2 2014 151M +151M Jul 3, 2014 10-Q/A 2014-07-23
Q1 2014 151M +2.08M +1.4% Apr 8, 2014 10-Q 2014-04-11
Q4 2013 151M +2.06M +1.38% Jan 6, 2014 10-K 2014-02-28
Q3 2013 151M +5.07M +3.47% Sep 30, 2013 10-Q 2013-10-02
Q2 2013 0 -141M -100% May 31, 2013 10-Q 2013-07-15
Q1 2013 149M +8.04M +5.7% Feb 28, 2013 10-Q 2013-04-12
Q4 2012 149M Jan 10, 2013 10-K/A 2013-02-28
Q3 2012 146M -24.9M -14.6% Oct 12, 2012 10-Q 2012-10-15
Q2 2012 141M Jul 12, 2012 10-Q 2012-07-16
Q1 2012 141M Apr 11, 2012 10-Q 2012-04-16
Q3 2011 171M Sep 30, 2011 10-Q 2011-10-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.